Joseph J. Ferra Jr - Jun 24, 2021 Form 4 Insider Report for Elevation Oncology, Inc. (ELEV)

Role
Chief Financial Officer
Signature
/s/ Shawn Leland, Attorney-in-Fact
Stock symbol
ELEV
Transactions as of
Jun 24, 2021
Transactions value $
$0
Form type
4
Date filed
6/28/2021, 06:23 PM
Next filing
Feb 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELEV Stock Option (Right to Buy) Award $0 +249K $0.00 249K Jun 24, 2021 Common Stock 249K $16.00 Direct F1
transaction ELEV Restricted Stock Unit (RSU) Award $0 +201K $0.00 201K Jun 24, 2021 Common Stock 201K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total shares will vest on June 16, 2022, and the remainder will vest as to 1/48 of the total award in monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date.
F2 Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration.
F3 25% of the RSUs will vest on June 16, 2022, and the remainder will vest in quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date.